FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885652183> ?p ?o ?g. }

• W2885652183 endingPage "2308" @default.
• W2885652183 startingPage "2297" @default.
• W2885652183 abstract "Abstract The TAM (TYRO3, AXL, MERTK) family receptor tyrosine kinases (RTK) play an important role in promoting growth, survival, and metastatic spread of several tumor types. AXL and MERTK are overexpressed in head and neck squamous cell carcinoma (HNSCC), triple-negative breast cancer (TNBC), and non–small cell lung cancer (NSCLC), malignancies that are highly metastatic and lethal. AXL is the most well-characterized TAM receptor and mediates resistance to both conventional and targeted cancer therapies. AXL is highly expressed in aggressive tumor types, and patients with cancer are currently being enrolled in clinical trials testing AXL inhibitors. In this study, we analyzed the effects of AXL inhibition using a small-molecule AXL inhibitor, a monoclonal antibody (mAb), and siRNA in HNSCC, TNBC, and NSCLC preclinical models. Anti-AXL–targeting strategies had limited efficacy across these different models that, our data suggest, could be attributed to upregulation of MERTK. MERTK expression was increased in cell lines and patient-derived xenografts treated with AXL inhibitors and inhibition of MERTK sensitized HNSCC, TNBC, and NSCLC preclinical models to AXL inhibition. Dual targeting of AXL and MERTK led to a more potent blockade of downstream signaling, synergistic inhibition of tumor cell expansion in culture, and reduced tumor growth in vivo. Furthermore, ectopic overexpression of MERTK in AXL inhibitor–sensitive models resulted in resistance to AXL-targeting strategies. These observations suggest that therapeutic strategies cotargeting both AXL and MERTK could be highly beneficial in a variety of tumor types where both receptors are expressed, leading to improved survival for patients with lethal malignancies. Mol Cancer Ther; 17(11); 2297–308. ©2018 AACR." @default.
• W2885652183 created "2018-08-22" @default.
• W2885652183 creator A5004455879 @default.
• W2885652183 creator A5014133933 @default.
• W2885652183 creator A5019310946 @default.
• W2885652183 creator A5025126021 @default.
• W2885652183 creator A5026053999 @default.
• W2885652183 creator A5030197429 @default.
• W2885652183 creator A5033923298 @default.
• W2885652183 creator A5034466183 @default.
• W2885652183 creator A5037575339 @default.
• W2885652183 creator A5037597725 @default.
• W2885652183 creator A5039868720 @default.
• W2885652183 creator A5040205022 @default.
• W2885652183 creator A5041770587 @default.
• W2885652183 creator A5043465379 @default.
• W2885652183 creator A5057953295 @default.
• W2885652183 creator A5073175528 @default.
• W2885652183 creator A5075808825 @default.
• W2885652183 creator A5085390573 @default.
• W2885652183 creator A5088036232 @default.
• W2885652183 creator A5089257042 @default.
• W2885652183 date "2018-11-01" @default.
• W2885652183 modified "2023-10-12" @default.
• W2885652183 title "MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents" @default.
• W2885652183 cites W1607701774 @default.
• W2885652183 cites W1932563524 @default.
• W2885652183 cites W1965661842 @default.
• W2885652183 cites W1983774108 @default.
• W2885652183 cites W1987848307 @default.
• W2885652183 cites W1990134250 @default.
• W2885652183 cites W1998266622 @default.
• W2885652183 cites W2004439203 @default.
• W2885652183 cites W2013022837 @default.
• W2885652183 cites W2022386424 @default.
• W2885652183 cites W2025879648 @default.
• W2885652183 cites W2040685978 @default.
• W2885652183 cites W2043841986 @default.
• W2885652183 cites W2044867944 @default.
• W2885652183 cites W2046142904 @default.
• W2885652183 cites W2052005627 @default.
• W2885652183 cites W2052988773 @default.
• W2885652183 cites W2058719858 @default.
• W2885652183 cites W2066516593 @default.
• W2885652183 cites W2077945404 @default.
• W2885652183 cites W2083870593 @default.
• W2885652183 cites W2089054568 @default.
• W2885652183 cites W2092225298 @default.
• W2885652183 cites W2096439168 @default.
• W2885652183 cites W2098983774 @default.
• W2885652183 cites W2103004313 @default.
• W2885652183 cites W2104775266 @default.
• W2885652183 cites W2111624138 @default.
• W2885652183 cites W2113765051 @default.
• W2885652183 cites W2121646539 @default.
• W2885652183 cites W2122375037 @default.
• W2885652183 cites W2126978518 @default.
• W2885652183 cites W2132286757 @default.
• W2885652183 cites W2142022948 @default.
• W2885652183 cites W2143902539 @default.
• W2885652183 cites W2149542744 @default.
• W2885652183 cites W2153636914 @default.
• W2885652183 cites W2154952294 @default.
• W2885652183 cites W2160226692 @default.
• W2885652183 cites W2169105660 @default.
• W2885652183 cites W2171749007 @default.
• W2885652183 cites W2199873185 @default.
• W2885652183 cites W2314772977 @default.
• W2885652183 cites W2413667427 @default.
• W2885652183 cites W2418914616 @default.
• W2885652183 cites W2465099763 @default.
• W2885652183 cites W2522576042 @default.
• W2885652183 cites W2555309153 @default.
• W2885652183 cites W2560005056 @default.
• W2885652183 cites W2561591210 @default.
• W2885652183 cites W2608688777 @default.
• W2885652183 cites W2620546513 @default.
• W2885652183 doi "https://doi.org/10.1158/1535-7163.mct-17-1239" @default.
• W2885652183 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6215511" @default.
• W2885652183 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30093568" @default.
• W2885652183 hasPublicationYear "2018" @default.
• W2885652183 type Work @default.
• W2885652183 sameAs 2885652183 @default.
• W2885652183 citedByCount "33" @default.
• W2885652183 countsByYear W28856521832018 @default.
• W2885652183 countsByYear W28856521832019 @default.
• W2885652183 countsByYear W28856521832020 @default.
• W2885652183 countsByYear W28856521832021 @default.
• W2885652183 countsByYear W28856521832022 @default.
• W2885652183 countsByYear W28856521832023 @default.
• W2885652183 crossrefType "journal-article" @default.
• W2885652183 hasAuthorship W2885652183A5004455879 @default.
• W2885652183 hasAuthorship W2885652183A5014133933 @default.
• W2885652183 hasAuthorship W2885652183A5019310946 @default.
• W2885652183 hasAuthorship W2885652183A5025126021 @default.
• W2885652183 hasAuthorship W2885652183A5026053999 @default.
• W2885652183 hasAuthorship W2885652183A5030197429 @default.
• W2885652183 hasAuthorship W2885652183A5033923298 @default.

• next